secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definium Therapeutics, Inc. (DFTX)
CIK:        0001813814
Form:       8-K
Filed at:   2025-10-29T23:59:59+00:00
Accession:  0001104659-25-103726
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MindMed reports preliminary cash ~$209.1M as of Sep 30, 2025
------------------------------------------------------------

- Preliminary cash, cash equivalents and investments total approximately $209.1M as of September 30, 2025.
- Data is unaudited and subject to KPMG review; may differ from final Q3 figures.
- Filed a prospectus supplement and posted an updated corporate presentation on October 29, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1813814/000110465925103726/0001104659-25-103726-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1813814/000110465925103726/tm2529652d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-103726

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer